Skip to search formSkip to main contentSkip to account menu

recombinant glycoprotein

Known as: glycoproteins recombinants 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Recombinant Glycoprotein Vaccines for Human Immunodeficiency Virus-Infected Children and Their Effects on Viral Quasispecies
ABSTRACT In individuals infected with human immunodeficiency virus type 1 (HIV-1), specific immunity is associated with a more… 
Review
1998
Review
1998
HIV vaccine development: a subtype E-specific strategy.
The pandemic of HIV/AIDS consists of multiple foci with distinct epidemiological characteristics. Among the approximately one… 
Review
1996
Review
1996
Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial
Development of a vaccine is crucial for controlling the global epidemic of human immunodeficiency virus type 1 (HIV-1) infection… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)